MedTrace Logo

BEOVU Versus Eylea in the Treatment of Diabetic Macular Edema

NCT04955171 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-07-08

No results posted yet for this study

Summary

Diabetic macular edema degeneration occur is a vision threatening condition. The investigators compare the efficacy of BEOVU and Eylea intravitreal treatment in the management

Conditions

  • Macular Edema

Interventions

DRUG

BEOVU intravitreal injection

BEOVU intravitreal injection

Sponsors & Collaborators

  • Benha University

    lead OTHER

Principal Investigators

  • TAREK ELHAMAKY, MD · Benha University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-12
Primary Completion
2022-03-31
Completion
2022-04-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04955171 on ClinicalTrials.gov